Glucotrol XL

See also: Generic Glucotrol

Glucotrol XL is a brand name of glipizide, approved by the FDA in the following formulation(s):

GLUCOTROL XL (glipizide - tablet, extended release; oral)

• 
  Manufacturer: PFIZER
  
  Approval date: April 26, 1994
  
  Strength(s): 10MG ^[RLD][AB], 5MG ^[AB]


• 
  Manufacturer: PFIZER
  
  Approval date: August 10, 1999
  
  Strength(s): 2.5MG ^[AB]

Has a generic version of Glucotrol XL been approved?

A generic version of Glucotrol XL has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Glucotrol XL and have been approved by the FDA:

glipizide tablet, extended release; oral

• 
  Manufacturer: WATSON LABS
  
  Approval date: September 8, 2003
  
  Strength(s): 5MG ^[AB]


• 
  Manufacturer: WATSON LABS
  
  Approval date: November 7, 2003
  
  Strength(s): 10MG ^[AB]


• 
  Manufacturer: WATSON LABS
  
  Approval date: March 27, 2006
  
  Strength(s): 2.5MG ^[AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Glucotrol XL. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Method for lowering blood glucose
  Patent 5,591,454
  Issued: January 7, 1997
  Inventor(s): Kuczynski; Anthony L. & Ayer; Atul D. & Wong; Patrick S.-L.
  Assignee(s): ALZA Corporation
  The invention disclosed comprises a method for administering the antidiabetic drug glipizide to a patient in need of glipizide in need of antidiabetic therapy.
  
  Patent expiration dates:
  
  
  • January 7, 2014
    
    ✓ 
    Patent use: METHOD OF USE FOR CONTROLLING HYPERGLYCEMIA BY ADMINISTRATION OF THIS SUSTAINED RELEASE DOSAGE FORM OF GLIPIZIDE
  
  
  
  • January 7, 2014
    
    ✓ 
    Patent use: DIABETES
  
  

See also...

• Glucotrol XL Extended-Release Tablets Consumer Information (Wolters Kluwer)
• Glucotrol XL Consumer Information (Cerner Multum)
• Glucotrol XL Advanced Consumer Information (Micromedex)
• Glipizide Consumer Information (Drugs.com)
• Glipizide Consumer Information (Wolters Kluwer)
• Glipizide Extended-Release Tablets Consumer Information (Wolters Kluwer)
• Glipizide Consumer Information (Cerner Multum)
• Glipizide Advanced Consumer Information (Micromedex)
• Glipizide AHFS DI Monographs (ASHP)